CL — Cresco Labs Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Cresco Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	224	119	103	138	57.9
Net Total Accounts Receivable
Net Total Receivables	44.7	56.9	52.5	52.1	39
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	422	326	278	294	259
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	457	508	486	456	427
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,780	1,584	1,358	1,355	1,197
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	288	281	200	94.3	100
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	1,025	957	853	881	857
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	756	627	506	475	340
Total Liabilities & Shareholders' Equity	1,780	1,584	1,358	1,355	1,197
Total Common Shares Outstanding